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doi:10.1016/j.jmii.2011.09.005Lethal toxic encephalopathy due to shigellosis or Ekiri syndrome is a rare complication of shig-
ellosis with a high fatality rate. Data are very limited on factors that can predict this encepha-
lopathy, so we evaluated clinical and laboratory characteristics for these patients. In this study
children with extreme toxicity and convulsions followed by rapid neurological deterioration re-
sulting in brain edema and fatal outcome without sepsis and severe dehydration were selected
as having lethal toxic encephalopathy. There were 1295 children with shigellosis during the 10
years of the study. Five children (0.4%) had lethal toxic encephalopathy due to shigellosis. Death
occurred following rapid neurological detoriation resulting in brain edema despite intensive
treatment. Evidence of brain edema may be a prediction factor for death. Early recognition
of encephalopathy and measures to prevent brain edema may improve patient outcome.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Shigellosis is a common infectious disease that results in
considerable morbidity and mortality, especially innt of Pediatric Infectious
ospital, School of Medicine,
s, 62 Gharib St., Keshavarz
s.ac.ir (S. Mamishi).
an Society of Microbiology. Publunderdeveloped countries. Almost two-thirds of worldwide
shigellosis occurs in children, and 99% in developing coun-
tries.1 The morbidity and mortality are predominantly due
to extraintestinal complications, especially in Shigella
encephalopathy, a serious neurologic complication often
manifest as altered consciousness, seizures, and coma.2,3
Neurological complications, particularly seizures fol-
lowed by encephalopathy and hallucinations, are among
the most common extraintestinal manifestations of shigel-
losis, with a prevalence of 12e45% in children.4,5 Peripheralished by Elsevier Taiwan LLC. All rights reserved.
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patients.6 In the minority of patients, encephalopathy may
be severe, unresponsive to antibiotic therapy, and fatal,
even in developed countries.7 A particular form of lethal
toxic encephalopathy due to shigellosis is characterized by
rapid onset of neurological abnormalities with only mild
colitis. It was first described in Japanese patients during
the first half of previous century and named the Ekiri
syndrome.8,9
Early recognition of lethal toxic encephalopathy using
prediction factors might improve patient outcome. Simple
clinical and sociodemographic characteristics might play
a role in predicting patient prognosis instead of focusing on
typing different Shigella species. Data are very limited on
such prediction factors, although a number of studies have
attempted to evaluate the clinical and laboratory charac-
teristics of such children.3,7,9 In this study we describe five
children who presented with lethal toxic encephalopathy
state due to shigellosis or Ekiri syndrome.
Patients and methods
This retrospective study was conducted at the Children’s
Medical Center Hospital, Tehran, Iran. We reviewed the
medical records of all hospitalized children for whom
Shigella spp. was isolated from a stool sample during
1999e2008. Among these patients, children with extreme
toxicity, convulsions, and hyperpyrexia followed by rapid
neurological deterioration resulting in brain edema and
fatal outcome without sepsis and severe dehydration were
selected as having lethal toxic encephalopathy due to
shigellosis. Information obtained from the patient records
included age, sex, symptoms (fever, vomiting, diarrhea)
prior to hospitalization, and clinical course. Information
from the physical examination included general condition,
fever, abdominal examination, quality of stool (water,
mucus, blood), and neurological status. Admission labora-
tory information included blood cell count, levels of serum
electrolytes, Shigella spp. isolates from stool cultures, and
antibiotic sensitivity results. Computed tomography was
also carried out if it was available.
Results
During this 10-year study, 1295 children ranging in age
from 1.5 months to 13 years with shigellosis were hospi-
talized in the Children’s Medical Center Hospital. There
were 680 (52.5%) boys and 615 (47.5%) girls. Most of the
patients (62.3%) were admitted to the hospital during
spring and summer. Five children (0.4%) with a mean age
of 7.1 years had lethal encephalopathy due to shigellosis.
Age and sex data for the five cases are shown in Table 1.
All of the patients were well-nourished healthy children
prior to their illness. Their previous medical history was
unremarkable. They had no neurological disorders and
head trauma, and use of possible culpable medication was
ruled out. No one in their immediate surroundings had
diarrhea.
All cases were admitted to hospital with a history of
fever, abdominal pain, recurrent vomiting, and the passage
of frequent brownish and later green diarrhea withoutblood or mucus. Illness duration prior to hospitalization was
2 days for Cases 1, 2, and 3, 1 day for Case 4, and 7 days for
Case 5. All cases had one episode of toniceclonic seizure
before admission that was controlled using diazepam in
another center. On arrival in the pediatric emergency
department, Cases 1, 3, and 4 were unconscious. Exami-
nation data, including blood pressure, pulse rate, respira-
tory rate, and temperature, are shown in Table 1. Cases 1
and 2 had severe hyperpyrexia. There were signs of mild to
moderate dehydration in all cases. Glasgow coma scores
were estimated as six for Cases 3, 4 and 5, and three for
Cases 1 and 2. Other physical examination results were
normal. All cases were referred to the intensive care unit
for further diagnostic evaluation and therapy.
Stool samples from all cases were cultured. Two cases
had S. flexneri in their stool, and samples from the other
three failed to agglutinate with Shigella spp. typing sera
(Table 1). Laboratory data are shown in Table 1. There was
severe neutropenia in Cases 1 and 3, and thrombocytopenia
in Case 3. Hyponatremia was seen in all cases. There were
calcium and potassium derangements in Cases 3 and 4.
Although there was clinical evidence of brain edema in
all cases, computed tomography of the brain was per-
formed only in one case because the other cases were
unstable. This revealed brain edema.
Dehydration and electrolytes derangements were
managed, and ceftriaxone was initiated in all cases.
Hyperventilation and mannitol were provided to treat the
brain edema. In spite of intensive treatment, the clinical
situation of the cases dramatically deteriorated and resul-
ted in their death.
Antibiotic susceptibility to ceftriaxone, nalidixic acid
amikacin was determined (Table 1). S. flexneri isolates
from Cases 1 and 3 were most sensitive to nalidixic acid.
Isolates from Case 3 were sensitive to amikacin.Discussion
This study reports five cases of fatal shigellosis during
a period of 10 years. From rapidly developing seizures and
altered consciousness followed by intestinal symptoms and
fever attributed to Shigella spp. infection, lethal toxic
encephalopathy or Ekiri syndrome was diagnosed. Death in
all cases occurred following rapid neurological deteriora-
tion that resulted in brain edema.
In our study all of the cases had seizures and three of
them were unconscious on arrival. In a previous study on
childhood shigellosis, being unconscious or having seizures
was strongly associated with death, but it is unclear if
seizures are simply a marker for more severe disease or
seizures actually contribute to death.10
A number of studies have reported lethal toxic enceph-
alopathy due to shigellosis in the past few years.2,3,7,9,11
One study reported three cases aged 9e11 years who
showed a typical encephalopathic clinical and pathological
pattern due to S. flexneri.2 Another report involved a 3.5-
year- old child who had encephalopathy and “Reye-like”
metabolic derangement due to S. flexneri.12 In the largest
series, 15 patients aged 5 months to 11 years died following
shigellosis in a 10-year period.3 The cause of death in all
patients was consistent with toxic encephalopathy and
Table 1 Clinical characteristics and laboratory findings at the time of admission for five cases of lethal encephalopathy due to
shigellosis
Parameter Case 1 Case 2 Case 3 Case 4 Case 5
Sex Female Female Male Male Female
Age (Y) 11 5 4 4 3.5
Temperature (C) 39 39.5 38.2 38.5 37.5
WBC (/mm3) 2000 6300 1000 5300 4700
Platelets (/mm3) 175,000 155,000 102,000 224,000 188,000
Na (meq/L) 130 132 126 133 133
K (meq/L) 3.9 3.5 3.1 2.3 3.9
Calcium (meq/L) 9 10.2 8 8.4 9
Stool RBC (/field) >50 d 5e7 10e12 d
Stool WBC (/field) >50 d 3e4 >50 d
Stool culture S. flexneri Shigella spp. S. flexneri Shigella spp. Shigella spp.
Antibiotic sensitivity Nalidixic acid Ceftriaxone Nalidixic acid and amikacin d d
RBC Z Red Blood Cell; WBC Z White Blood Cell.
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teriae. Only headache was a prominent feature of patients
who died. In our study, two cases had S. flexneri in stool
samples and agglutination with Shigella typing sera was
negative for samples from the other three cases. In a recent
study, the most common species of Shigella in Iranian
children were S. flexneri (48%) and S. sonnei (45%).13
The pathogenesis of lethal encephalopathy due to shig-
ellosis or Ekiri remains unknown. It has been postulated
that Shiga toxin, which is only produced by Shigella dys-
enteriae type 1, plays a role.4,14 However, the other three
Shigella species that have been isolated from infants
usually do not produce the toxin. In our study, two cases
had S. flexneri. Thus, Shiga toxin production may be not
essential for this lethal complication,2,15 often associated
with brain edema or hemorrhage.2 Previous studies sug-
gested that brain edema occurs in patients with shigellosis
and lethal toxic encephalopathy.2,3,5,7,9,11 In our study, all
cases had clinical evidence of brain edema, and computed
tomography in one case confirmed this. Thus, evidence of
brain edema may be useful as a prediction factor for fatal
outcome.
It is possible that the premorbid state (mental retarda-
tion, coinfection) or metabolic abnormalities have no
influence. Hypocalcemia was considered to have a patho-
genic role in Japanese children with Ekiri.9 The authors
suggested that dietary supplementation with calcium might
reduce the incidence of Ekiri. However, signs of central
nervous system involvement and circulatory collapse
remained in a patient with Ekiri given calcium therapy.9 In
our study, two cases had mild hypocalcemia, but this is
considered insignificant in the pathogenesis of lethal
encephalopathy. Hyponatremia was seen in all cases in this
study. Although previous studies on shigellosis reported
hyponatremia in association with seizures, they did not
identify this as a risk factor for the development of
seizures.5 A number of studies on lethal encephalopathy
due to shigellosis found hyponatremia,3,7 but hyponatremia
was not considered significant in the pathogenesis of this
neurological catastrophe.
The ability of antibiotic treatment to prevent serious
complications due to shigellosis has not been proven.2,4,5 Inone case of a 3-year-old child with encephalopathy due to
shigellosis, empiric initiation of ceftriaxone, dexametha-
sone, and acyclovir was effective and the child survived.7 In
our study, intensive treatment was not successful which
may be due to a resistant organism or delayed initiation of
treatment. Increased Shigella spp. resistance has been
observed in Iranian children.16 Early introduction of
appropriate antimicrobial treatment in a could help solving
this question. S. flexneri from Cases 1 and 3 in our study
was sensitive to nalidixic acid, which is still one of the most
appropriate antibiotics for treatment of shigellosis due to
Shigella spp. especially S. flexneri.13
In summary, this study reported five cases of lethal toxic
encephalopathy associated with shigellosis or Ekiri
syndrome. Death occurred following rapid neurological
detoriation resulting in brain edema despite intensive
treatment. Evidence of brain edema may be a prediction
factor for death. Early recognition of encephalopathy and
measures to prevent brain edema may improve patient
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